Thursday | 20 November, 2008
Stories about: Myriad Genetics
- +
GTG responds to BRCA row 24/07/2008 13:36:01
Genetic Technologies responds to criticism over patent enforcement decision - +
Genetic Technologies gets tough 14/07/2008 12:55:36
GTG to enforce rights to BRCA patents - +
GTG primed to expand non-coding DNA licensing 30/01/2006 09:29:30
Mervyn Jacobson, executive chairman of biotech firm Genetic Technologies (ASX:GTG, Nasdaq:GENE), says his company is poised to launch an extensive international search for license partners for its far-reaching non-coding DNA patents. - +
Interview: Charting a course towards a cure 22/03/2005 12:55:39
Joe Sambrook tells Susan Williamson about the opportunities and challenges in understanding, treating and, ultimately, preventing breast cancer. - +
Interview: King for a year 22/03/2005 12:47:03
One of the keynote speakers at the 2003 Lorne Cancer conference was breast cancer researcher Mary-Claire King. She tells Bio-IT World's Kevin Davies about a remarkable life in research. - +
Gene patent system ain't broke, but needs fine tuning: ALRC 06/09/2004 14:45:47
A report by the Australian Law Reform Commission (ALRC) following an 18-month inquiry into genetic patents has concluded that significant patent law reforms are needed to accommodate cutting-edge genetic technology. - +
NZ health service takes on GTG over licence fees 24/08/2004 14:36:50
On the eve of its landmark patent-infringement case against US gene-testing company Applera Corp, Melbourne-based Genetic Technologies (ASX:GTG) has been hit with a New Zealand challenge to its right to charge licence fees for access to its non-coding DNA patents. - +
Gruber genetics prize goes to cancer researcher King 28/06/2004 15:23:20
The US$200,000 Peter Gruber Prize in Genetics for 2004 has been awarded to Mary-Claire King, the University of Washington geneticist who paved the way for the identification of the BRCA1 hereditary breast and ovarian cancer gene in 1994. - +
BIO profile: Mervyn Jacobson, Genetic Technologies 01/06/2004 15:20:36
A keen fascination in the creative ideas of others and a willingness to take risks are hallmarks of Australian biotechnology entrepreneur Dr Mervyn Jacobson's outlook on life. - +
EU patent snatchback won't affect GTG: Jacobson 21/05/2004 16:06:45
The European Patent Office's decision to revoke a key patent on a breast cancer test owned by Utah-based Myriad Genetics will not prevent Myriad's Australian licensee, Genetic Technologies Ltd (ASX: GTG) providing the test in Australia and Asia. - +
US giant LabCorp signs up for GTG license 09/02/2004 14:03:16
Melbourne company Genetic Technologies (ASX:GTG) has added another large US company to its tally, with Laboratory Corporation of America Holdings -- otherwise known as LabCorp -- becoming the latest to license the company's non-coding DNA mapping and analysis patents.
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
Kingston Technology Launches HyperX T1 Series Memory 2008-11-19 11:00:00+11
Erase your discs with Lite-On SmartErase 2008-11-12 14:00:00+11
Antarctica NZ to Optimise Satellite Communications over the WAN with Expand Networks 2008-11-11 08:22:00+11
Kingston Technology Launches HyperX DDR3 2GHz Triple-Channel Memory in Support of Intel Core i7, X58 Platforms 2008-11-06 16:40:00+11
WD TV™ HD Media Player brings Digital Media Collections to the Big Screen 2008-11-05 11:00:00+11
Sponsored Links
Subscribe to Australian Life Scientist
Australian Life Scientist is Australia's leading magazine for the life sciences sector.
